Conversely, inhibition of VEGF-signaling during DC maturation in vitro or by treating tumor-bearing mice with sunitinib in vivo has previously been demonstrated to inhibit DC activation [20, 21]. The gene discussed is VEGFA; the disease is neoplasm.